Jennifer E Gerber
Overview
Explore the profile of Jennifer E Gerber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salamanca de la Cueva I, Gerber J, Hastie A, Brotons C, Panzer F, Pircon J, et al.
Drug Saf
. 2024 Jul;
47(11):1137-1148.
PMID: 38949714
Background: Seasonal influenza is prevented through annual vaccination, especially in children and older adults. These vaccines are annually updated based on World Health Organization recommendations and require continuous safety monitoring....
2.
Dudley M, Schwartz B, Brewer J, Kan L, Bernier R, Gerber J, et al.
Vaccine
. 2023 Nov;
41(49):7395-7408.
PMID: 37951793
Objectives: To compare vaccine-related attitudes and values of parents of children 2-17 years old to other adults, examine intentions to vaccinate their children, and identify factors associated with intending to...
3.
Dudley M, Gerber J, Budigan Ni H, Blunt M, Holroyd T, Carleton B, et al.
Vaccine
. 2023 Feb;
41(14):2357-2367.
PMID: 36803903
Background: This scoping review summarizes a key aspect of vaccinomics by collating known associations between heterogeneity in human genetics and vaccine immunogenicity and safety. Methods: We searched PubMed for articles...
4.
Dudley M, Schwartz B, Brewer J, Kan L, Bernier R, Gerber J, et al.
J Clin Med
. 2022 Jul;
11(13).
PMID: 35807016
Background: The Delta COVID-19 variant caused a resurgence in cases and deaths during the summer of 2021, particularly among the unvaccinated, highlighting the need to increase vaccine coverage. We describe...
5.
Gerber J, Brewer J, Limaye R, Sutherland A, Blunt M, Holroyd T, et al.
Hum Vaccin Immunother
. 2021 Jun;
17(9):2999-3015.
PMID: 34152932
: We characterize public values regarding vaccinomics, which aims to improve vaccine safety and effectiveness using genomics. Panel survey (2020) of ≥18-year-olds with embedded animation introduced vaccinomics. Sociodemographic, health, and...
6.
Holroyd T, Limaye R, Gerber J, Rimal R, Musci R, Brewer J, et al.
J Health Commun
. 2021 May;
26(4):272-280.
PMID: 33998402
Infectious disease outbreaks highlight the importance of trust in public health authorities to avoid fear and improve adherence to recommendations. There is currently no established and validated measure for trust...
7.
Gerber J, Geller G, Boyce A, Maragakis L, Garibaldi B
Health Secur
. 2021 Apr;
19(3):318-326.
PMID: 33826422
The impact of host genomics on an individual's susceptibility, immune response, and risk of severe outcomes for a given infectious pathogen is increasingly recognized. As we uncover the links between...
8.
Salmon D, Dudley M, Brewer J, Kan L, Gerber J, Budigan H, et al.
Vaccine
. 2021 Mar;
39(19):2698-2711.
PMID: 33781601
Introduction: Safe and effective vaccines against Coronavirus Disease 2019 (COVID-19) provide the best opportunity to control the pandemic. Having safe and efficacious vaccines available is only half the equation; people...
9.
Ethical and policy implications of vaccinomics in the United States: community members' perspectives
Gerber J, Brewer J, Limaye R, Sutherland A, Geller G, Spina C, et al.
Hum Vaccin Immunother
. 2021 Feb;
17(7):2133-2144.
PMID: 33626296
: We aimed to elucidate public values regarding the use of genomics to improve vaccine development and use (vaccinomics).: Adults ≥18 years-old were recruited through social media and community organizations,...
10.
Rettig E, Wentz A, Posner M, Gross N, Haddad R, Gillison M, et al.
JAMA Oncol
. 2015 Jul;
1(7):907-15.
PMID: 26226294
Importance: Human papillomavirus-related oropharyngeal carcinoma (HPV-OPC) is increasing in incidence in the United States. Although HPV-OPC has favorable prognosis, 10% to 25% of HPV-OPCs recur. Detection of human papillomavirus (HPV)...